This study is focused on fundamental analysis of pharmaceutical companies listed in National Stock Exchange (NSE), which include selected five companies for a period of five years from 2011 to 2015. The fundamental analysis consists of three parts such as economic analysis, industry analysis and company analysis. | Fundamental analysis with special reference to pharmaceutical companies listed in NSE INTERNATIONAL JOURNAL OF MANAGEMENT IJM ISSN 0976-6502 Print ISSN 0976-6510 Online A STUDY IJM Volume 7 Issue 2 February 2016 pp. 123-133 http ijm IAEME Journal Impact Factor 2016 Calculated by GISI FUNDAMENTAL ANALYSIS WITH SPECIAL REFERENCE TO PHARMACEUTICAL COMPANIES LISTED IN NSE Ms. J. Hema Assistant Professor . Engineering College Sivakasi - 626140 V. Ariram MBA Scholar . Engineering College Sivakasi - 626140 ABSTRACT An investment analysis is essential for the benefit of risk reduction and maximizes the gain. The investment analysis on stock market has two main approaches namely technical analysis and fundamental analysis. This study is focused on fundamental analysis of pharmaceutical companies listed in National Stock Exchange NSE which include selected five companies for a period of five years from 2011 to 2015. The fundamental analysis consists of three parts such as economic analysis industry analysis and company analysis. The economic analysis consists of economic indicators which influence the security market like GDP inflation interest rate foreign reserves export and agricultural production for the study period. An industry analysis includes industrial compound annual growth rate sales revenue and global market share etc. For company analysis various performance ratios such as EPS DPS Net profit Margin Debt to equity ratio etc. are used. Industry analysis shows that the Indian pharmaceutical industry has high growth rate and company analysis revealed that Lupin and Torrent pharma are financially viable during the study period. Key words Fundamental analysis Indian Pharmaceutical Industry GDP Economic Cite this Article J. Hema and V. Ariram Fundamental Analysis with Special Reference to Pharmaceutical Companies Listed in NSE. International Journal of Management 7 2 2016 pp. 123-133. http IJM .
